Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003023591 | SCV003320810 | likely benign | Nemaline myopathy 2 | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003170893 | SCV003871656 | uncertain significance | Inborn genetic diseases | 2023-02-06 | criteria provided, single submitter | clinical testing | The c.15034G>C (p.V5012L) alteration is located in exon 104 (coding exon 102) of the NEB gene. This alteration results from a G to C substitution at nucleotide position 15034, causing the valine (V) at amino acid position 5012 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |